Genethera Inc (GTHR) financial statements (2021 and earlier)

Company profile

Business Address 3051 W 105TH AVENUE
WESTMINSTER, CO 80031
State of Incorp. NV
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 55168  0
Cash and cash equivalents 55168  0
Receivables     2215
Total current assets: 55168 2215
Noncurrent Assets
Property, plant and equipment 162126  784
Other noncurrent assets   12 111 
Other undisclosed noncurrent assets  12  13(784)
Total noncurrent assets: 163338 124 
TOTAL ASSETS: 2138206 14615
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 6,1205,8734,8194,3864,1426,390
Accounts payable 287766847259261,245
Accrued liabilities 6,0925,0974,1363,6613,2172,630
Employee-related liabilities      2,515
Debt 26265151,38067211
Due to related parties 742771 1,029268272
Other liabilities    326  
Other undisclosed current liabilities 551,301  1,588(918)
Total current liabilities: 6,9427,9705,3347,1216,6705,754
Noncurrent Liabilities
Other undisclosed liabilities   2,059   
Total liabilities: 6,9427,9707,3937,1216,6705,754
Stockholders' equity
Stockholders' equity attributable to parent, including: (6,921)(7,932)(7,187)(7,121)(6,578)(5,766)
Preferred stock   0151515
Common stock 363640943734
Additional paid in capital 23,44922,56919,27418,58318,40518,161
Accumulated deficit (30,485)(30,616)(26,571)(25,814)(25,035)(23,949)
Other undisclosed stockholders' equity attributable to parent 808070  (27)
Other undisclosed stockholders' equity     5427
Total stockholders' equity: (6,921)(7,932)(7,187)(7,121)(6,524)(5,739)
TOTAL LIABILITIES AND EQUITY: 2138206 14615

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Operating expenses (739)(3,927) (680)(901)(225)
Other operating income, net
(Other Expenses)
      63
Operating loss: (739)(3,927) (680)(901)(162)
Nonoperating income
(Other Nonoperating income)
    39  
Interest and debt expense (29)(118) 138(185)63
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 250(0)    
Loss from continuing operations before equity method investments, income taxes: (518)(4,045) (504)(1,085)(100)
Other undisclosed loss from continuing operations before income taxes    (275)  
Loss before gain (loss) on sale of properties: (518)(4,045) (779)(1,085)(100)
Other undisclosed net loss   (758)   
Net loss: (518)(4,045)(758)(779)(1,085)(100)
Other undisclosed net loss attributable to parent      (447)
Net loss available to common stockholders, diluted: (518)(4,045)(758)(779)(1,085)(546)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (518)(4,045)(758)(779)(1,085)(100)
Comprehensive loss, net of tax, attributable to parent: (518)(4,045)(758)(779)(1,085)(100)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: